Lars Farde

Christer Halldin, Lars Farde, Jarkko Johansson, 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study

Yuan-Hwa Chou, Christer Halldin, Lars Farde, 2003, Psychopharmacology.

Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain.

Christer Halldin, Lars Farde, Magdalena Nord, 2013, The international journal of neuropsychopharmacology.

5-HT2 and D2 dopamine receptor occupancy in the living human brain

Christer Halldin, Lars Farde, Svante Nyberg, 1993, Psychopharmacology.

[11C]β‐CIT‐FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography

Christer Halldin, Lars Farde, Per Karlsson, 1996 .

In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects

Simon Cervenka, Christer Halldin, Lars Farde, 2016, Brain, Behavior, and Immunity.

The advantage of using positron emission tomography in drug research

Lars Farde, L. Farde, 1996, Trends in Neurosciences.

PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor

Christer Halldin, Lars Farde, Per Karlsson, 2005, Psychopharmacology.

PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls

Jan-Eric Litton, Christer Halldin, Lars Farde, 1993, Psychiatry Research: Neuroimaging.

Brain imaging of schizophrenia—the dopamine hypothesis

Lars Farde, L. Farde, 1997, Schizophrenia Research.

[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.

Yuan-Hwa Chou, Denis Guilloteau, Christer Halldin, 2003, European journal of nuclear medicine and molecular imaging.

Lars Farde, Kjell Någren, Jarmo Hietala, 2000, Neurobiology of Aging.

Measurement of serotonin transporter binding with PET and [11C]MADAM: A test–retest reproducibility study

Christer Halldin, Lars Farde, Johan Lundberg, 2006, Synapse.

Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.

Christer Halldin, Lars Farde, Hans Olsson, 2003, The international journal of neuropsychopharmacology.

Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain

Christer Halldin, Lars Farde, Göran Sedvall, 1994, Neuropsychopharmacology.

Dopamine D 2/3 Receptor Occupancy of Apomorphine in the Nonhuman Primate Brain—A Comparative PET Study With

Christer Halldin, Lars Farde, Balázs Gulyás, 2022 .

Quantification of Blood Flow-Dependent Component in Estimates of Beta-Amyloid Load Obtained Using Quasi-Steady-State Standardized Uptake Value Ratio

Lars Farde, Zsolt Cselényi, L. Farde, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT

Christer Halldin, Lars Farde, Andrea Varrone, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity

Christer Halldin, Lars Farde, Hans Forssberg, 2005, Biological Psychiatry.

Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data

Pontus Plavén-Sigray, Simon Cervenka, Lars Farde, 2017, EJNMMI Research.

Pharmacological Characterization ofN,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity

Denis Guilloteau, Christer Halldin, Lars Farde, 2003, Journal of Pharmacology and Experimental Therapeutics.

Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand

Lars Farde, Britt-Marie Swahn, Johan Sandell, 2010, Journal of neurochemistry.

Maps of receptor binding parameters in the human brain — a kinetic analysis of PET measurements

Christer Halldin, Lars Farde, Stefan Pauli, 2004, European Journal of Nuclear Medicine.

Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders

Pontus Plavén-Sigray, Simon Cervenka, Lars Farde, 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

Application of cross-species PET imaging to assess neurotransmitter release in brain

Christer Halldin, Lars Farde, Sjoerd J. Finnema, 2015, Psychopharmacology.

Error Analysis for Quantification of [11C]FLB 457 Binding to Extrastriatal D2 Dopamine Receptors in the Human Brain

Christer Halldin, Lars Farde, Yoshiro Okubo, 2001, NeuroImage.

[11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET

Denis Guilloteau, Christer Halldin, Lars Farde, 2005, Synapse.

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Christer Halldin, Lars Farde, Katarina Varnäs, 2015, Brain : a journal of neurology.

No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone

Christer Halldin, Lars Farde, Lars Eriksson, 1995, Psychiatry Research: Neuroimaging.

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder

Christer Halldin, Lars Farde, Johan Lundberg, 2012, The international journal of neuropsychopharmacology.

Confirmation of Fenfluramine Effect on 5-HT1B Receptor Binding of [11C]AZ10419369 using an Equilibrium Approach

Christer Halldin, Lars Farde, Andrea Varrone, 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC

Christer Halldin, Lars Farde, Göran Sedvall, 1994 .

Using positron emission tomography to facilitate CNS drug development.

Lars Farde, L. Farde, Chi-Ming Lee, 2006, Trends in pharmacological sciences.

Qualitative and quantitative MALDI imaging of the positron emission tomography ligands raclopride (a D2 dopamine antagonist) and SCH 23390 (a D1 dopamine antagonist) in rat brain tissue sections using a solvent-free dry matrix application method.

Lars Farde, Anna Nilsson, Richard J A Goodwin, 2011, Analytical chemistry.

A novel principle of radiotracer administration in human brain mapping: pet studies on brain uptake and distribution of orally and intravenously administered [11C]vinpocetine

Christer Halldin, Lars Farde, Per Karlsson, 2001, NeuroImage.

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

Christer Halldin, Lars Farde, Anna-Lena Nordström, 2005, Psychopharmacology.

A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain

Christer Halldin, Lars Farde, Johan Lundberg, 2007, Psychopharmacology.

Positron Emission Tomography Studies on Dopamine Receptors in Schizophrenia

Christer Halldin, Lars Farde, Per Karlsson, 1995 .

Genetic Variation in Brain-Derived Neurotrophic Factor Is Associated with Serotonin Transporter but Not Serotonin-1A Receptor Availability in Men

Lars Farde, Mats Lindström, Erik Ryding, 2009, Biological Psychiatry.

Potentials and Pitfalls Using High Affinity Radioligands in PET and SPET Determinations on Regional Drug Induced D2 Receptor Occupancy—A Simulation Study Based on Experimental Data

Lars Farde, Hans Olsson, L. Farde, 2001, NeuroImage.

Saturation analysis of specific 11C Ro 15‐1788 binding to the human neocortex using positron emission tomography

Christer Halldin, Lars Farde, Sharon Stone-Elander, 1989 .

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

Christer Halldin, Lars Farde, Anna-Lena Nordström, 1993, Biological Psychiatry.

Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain

Pontus Plavén-Sigray, Simon Cervenka, Christer Halldin, 2019 .

Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates

Christer Halldin, Lars Farde, Katarina Varnäs, 2015, The international journal of neuropsychopharmacology.

Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)-7-iodo-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine (NNC 13-8241)

Christer Halldin, Lars Farde, Jyrki T. Kuikka, 1996, European Journal of Nuclear Medicine.

The MINDVIEW project: First results

Julien Bert, Carl Jackson, Lars Farde, 2018, European Psychiatry.

A PET study of D1-like dopamine receptor ligand binding

Christer Halldin, Lars Farde, Hans Olsson, 1999, Psychopharmacology.

PET Mapping of Extrastriatal D2-like Dopamine Receptors in the Human Brain Using an Anatomic Standardization Technique and [11C]FLB 457

Christer Halldin, Lars Farde, Yoshiro Okubo, 1999, NeuroImage.

Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients

Christer Halldin, Lars Farde, Svante Nyberg, 1996, Psychiatry Research: Neuroimaging.

Measurement of Methylphenidate-Induced Change in Extrastriatal Dopamine Concentration using [11C]FLB 457 PET

Lars Farde, Marie-Claude Asselin, Andrew J Montgomery, 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Common brain disorders are associated with heritable patterns of apparent aging of the brain

Anders M. Dale, Lars T. Westlye, Mona K. Beyer, 2019, Nature Neuroscience.

D2 dopamine receptors and personality traits

J. Petter Gustavsson, Lars Farde, Erik Jönsson, 1997, Nature.

Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907

Lars Farde, Stefan Pauli, Göran Sedvall, 1996, Psychopharmacology.

Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET.

Christer Halldin, Lars Farde, Yoshiro Okubo, 1999, The international journal of neuropsychopharmacology.

Effect of reserpine‐induced depletion of synaptic dopamine on [11C]Raclopride binding to D2‐dopamine receptors in the monkey brain

Christer Halldin, Lars Farde, Nathalie Ginovart, 1997, Synapse.

Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study

Christer Halldin, Lars Farde, Ikuo Odano, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans.

Christer Halldin, Lars Farde, Johan Lundberg, 2009, The international journal of neuropsychopharmacology.

A PET study of [11C]β-CIT-FE binding to the dopamine transporter in the monkey and human brain

Yuan-Hwa Chou, Christer Halldin, Lars Farde, 2000 .

[11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain

Yuan-Hwa Chou, Denis Guilloteau, Christer Halldin, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[18F]β-CIT-FP is superior to [11C]β-CIT-FP for quantitation of the dopamine transporter

Christer Halldin, Lars Farde, Nathalie Ginovart, 1997 .

Thinking Outside a Less Intact Box: Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals

Simon Cervenka, Lars Farde, Anke Karabanov, 2010, PloS one.

Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography

Christer Halldin, Lars Farde, Yoshiro Okubo, 2006, Psychiatry Research: Neuroimaging.

AZD2184: a radioligand for sensitive detection of β‐amyloid deposits

Lars Farde, Johan Sandell, David Wensbo, 2009, Journal of neurochemistry.

A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.

Christer Halldin, Lars Farde, Nicholas Seneca, 2005, Nuclear medicine and biology.

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients

Christer Halldin, Lars Farde, Katarina Varnäs, 2013, European Journal of Nuclear Medicine and Molecular Imaging.